Icon

AQNEURSA - (1000MG)

LEVACETYLLEUCINE None
1000MG
Less Than $1000 mn
None None
None None
None None
AQNEURSA is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg.
Yes
AQNEURSA Patent 1 Patent 2 Patent 3
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.